CD8A and neoplasm: As shown in Supplementary Fig. 17e–h, biNV-IL-15 obviously improved the percentage of tumor-infiltrating CD8+ T cells and downregulated the level of immunosuppressive Tregs in tumor, implying remarkable advantages over IL-15:IL-15Rα and IL-15:IL-15Rα+biNV.